In recent years, the psychedelic renaissance has captured the attention of investors seeking opportunities in the burgeoning field of mental health treatment. As societal attitudes towards psychedelics shift and research reveals their potential therapeutic benefits, a new frontier of investment has emerged: psychedelic company stocks.
